A Study to Evaluate the Safety and Effectiveness of Blinatumomab in Combination with Oral Tyrosine Kinase Inhibitors as a Consolidative Therapy in Adult Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Latest Information Update: 06 Jan 2020
At a glance
- Drugs Blinatumomab (Primary) ; Dasatinib (Primary) ; Imatinib (Primary) ; Nilotinib (Primary) ; Ponatinib (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 06 Jan 2020 New trial record